![](/img/cover-not-exists.png)
The Impact of the Addition of Pertuzumab to Neoadjuvant HER2 Targeting on Pathological Complete Response (pCR) Rates: Kent Oncology Centre (KOC) Experience
Sim, V., Forner, S., Burcombe, R., Glendenning, J.Volume:
31
Language:
english
Journal:
Clinical Oncology
DOI:
10.1016/j.clon.2019.03.034
Date:
July, 2019
File:
PDF, 53 KB
english, 2019